Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MCRB – Seres Therapeutics, Inc.

Seres Therapeutics, Inc.
MCRB
$11.11
Name : Seres Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $97,017,184.00
EPSttm : -7.95
finviz dynamic chart for MCRB
Seres Therapeutics, Inc.
$11.11
22.09%
$2.01

Float Short %

10.55

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

1.62

EPS Last/This Y

-3.58

EPS This/Next Y

-1.43

Price

11.12

Target Price

13.33

Analyst Recom

2.6

Performance Q

-22.95

Relative Volume

3.64

Beta

2.66

Ticker: MCRB




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02MCRB6.990.060.006238
2025-06-03MCRB70.060.006247
2025-06-04MCRB7.070.060.006247
2025-06-05MCRB7.140.060.006254
2025-06-06MCRB8.210.060.406265
2025-06-09MCRB7.980.061.646267
2025-06-10MCRB8.230.0618.006292
2025-06-11MCRB8.030.0618.006292
2025-06-12MCRB80.060.006300
2025-06-13MCRB7.540.062.006310
2025-06-16MCRB7.50.060.086308
2025-06-17MCRB7.480.060.006437
2025-06-18MCRB7.620.065.006619
2025-06-20MCRB7.510.060.326630
2025-06-23MCRB7.360.050.006412
2025-06-24MCRB8.410.050.006596
2025-06-25MCRB9.450.050.006726
2025-06-26MCRB9.430.050.006979
2025-06-27MCRB9.140.050.007002
2025-06-30MCRB11.10.050.007028
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02MCRB7.0040.7- -3.58
2025-06-03MCRB7.0040.7- -3.58
2025-06-04MCRB7.1140.7- -3.58
2025-06-05MCRB7.2640.7- -3.58
2025-06-06MCRB8.1340.7- -3.58
2025-06-09MCRB8.1540.7- -3.58
2025-06-10MCRB8.2340.7- -3.58
2025-06-11MCRB8.0740.7- -3.58
2025-06-12MCRB7.9940.7- -3.58
2025-06-13MCRB7.5640.7- -3.58
2025-06-16MCRB7.5340.7- -3.58
2025-06-17MCRB7.3440.7- -3.58
2025-06-18MCRB7.7340.7- -3.58
2025-06-20MCRB7.4040.7- -3.58
2025-06-23MCRB7.4040.7- -3.58
2025-06-24MCRB8.3140.7- -3.58
2025-06-25MCRB9.5840.7- -3.58
2025-06-26MCRB9.4840.7- -3.58
2025-06-27MCRB9.0340.7- -3.58
2025-06-30MCRB11.1240.7- -3.58
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02MCRB-1.26-3.9212.41
2025-06-03MCRB-1.26-3.9212.41
2025-06-04MCRB-1.26-3.9212.41
2025-06-05MCRB-1.26-3.9212.41
2025-06-06MCRB-1.26-3.9212.41
2025-06-09MCRB-1.26-4.2312.41
2025-06-10MCRB-1.26-4.2312.41
2025-06-11MCRB-1.26-4.2311.04
2025-06-12MCRB-1.26-4.2311.04
2025-06-13MCRB-1.26-4.2311.04
2025-06-16MCRB-1.26-43.1911.04
2025-06-18MCRB-1.26-43.1911.04
2025-06-20MCRB-1.26-43.1911.04
2025-06-23MCRB-1.26-43.1911.04
2025-06-24MCRB-1.26-43.1911.04
2025-06-25MCRB-1.26-43.1911.04
2025-06-26MCRB-1.26-43.1910.55
2025-06-27MCRB-1.26-43.1910.55
2025-06-30MCRB-1.26-43.1910.55
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

-2.24

Avg. EPS Est. Current Quarter

-2.61

Avg. EPS Est. Next Quarter

-0.62

Insider Transactions

-1.26

Institutional Transactions

-43.19

Beta

2.66

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

5

Fair Value

Quality Score

54

Growth Score

18

Sentiment Score

49

Actual DrawDown %

98.6

Max Drawdown 5-Year %

-99.1

Target Price

13.33

P/E

Forward P/E

PEG

P/S

P/B

1.92

P/Free Cash Flow

EPS

-9.99

Average EPS Est. Cur. Y​

-3.58

EPS Next Y. (Est.)

-5.01

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

3.64

Return on Equity vs Sector %

120.7

Return on Equity vs Industry %

139.8

EPS 1 7Days Diff

-3.7

EPS 1 30Days Diff

-2.46

EBIT Estimation

Seres Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 103
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize gastrointestinal pathogens, enhance epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. Its other pipeline programs include SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease; and SER-287 and SER-301, which are in clinical trials for the treatment of mild-to-moderate ulcerative colitis. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
stock quote shares MCRB – Seres Therapeutics, Inc. Stock Price stock today
news today MCRB – Seres Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MCRB – Seres Therapeutics, Inc. yahoo finance google finance
stock history MCRB – Seres Therapeutics, Inc. invest stock market
stock prices MCRB premarket after hours
ticker MCRB fair value insiders trading